Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Early Phase Study of an EGFRvIII Peptide Based Vaccine in Patients With EGFRvIII Expressing Cancers

NCT00023634 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.

NCT NCT00023634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00023634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Early Phase Study of an EGFRvIII Peptide Based Vaccine in Patients With EGFRvIII Expressing Cancers
Lead sponsor
SWOG Cancer Research Network
Phase
Phase 1
Overall status
Terminated
Start date
June 30, 2001
Completion date
November 30, 2008
Enrollment
14 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumors, gastric cancer, ovarian cancer, prostate cancer